Tarak Mody, based in California, United States, is currently a Chief Business Officer at Parker Institute for Cancer Immunotherapy, bringing experience from previous roles at Self-employed, Five Prime Therapeutics, Inc. (acquired by Amgen, Inc.) and Pharmacyclics, Inc. (an AbbVie company) - 20 year employee. Tarak Mody holds a 1988 - 1993 Ph.D in Bioinorganic Chemistry/Synthetic Chemistry @ The University of Texas at Austin. With a robust skill set that includes Thesis, Mesa, Hematology, Milestone, Foundation and more, Tarak Mody contributes valuable insights to the industry. Tarak Mody has 2 emails on RocketReach.